Paci E, Buiatti E, Costantini AS, Miligi L, Pucci N, Scarpelli A, Petrioli G, Simonato L, Winkelmann R, Kaldor JM (1989) Aplastic anemia, leukemia and other cancer mortality in a cohort of shoe workers exposed to benzene. Scand.J.Work.Environ.Health 15:313-318 Park, D. J., and Koeffler, H. P. (1996). Therapy-related myelodysplastic syndromes. Semin.Hematol. 33, 256-273. Parodi, S., Lutz, W.K., Colacci, A., et al. 1989. Results of animal studies suggest a nonlinear dose-response relationship <strong>for</strong> benzene effects. Environ Health Perspect 82: 171-176. Pathak, D. N., Lévay, G., and Bodell, W.J. 1995. DNA adduct <strong>for</strong>mation in the bone marrow of B6C3 F1 mice treated with benzene. Carcinogenesis 16: 1803-1808. Paustenbach, D. J., Price, P. S., Ollison, W., Blank, C., Jernigan, J. D., Bass, R. D., and Peterson, H. D. (1992). Reevaluation of benzene exposure <strong>for</strong> the pliofilm (rubberworker) cohort (1936-1976). J.Toxicol.Environ.Health 36, 177-231. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV (1994) Leukemia risk associated with benzene exposure in the Pliofilm cohort: I. mortality update and exposure distribution. Risk Anal. 14:147-154. Paxton MB, Chinchilli VM, Brett SM, Rodricks JV (1992) Reanalysis and update of the leukemogenic risk associated with occupational benzene exposure in the pliofilm cohort. (UnPub). Pedersen-Bjergaard, J., Larsen, S., Struck, J., Hansen, H., Specht, L., Ersboll, J., Hansen, M., and Nissen, N. (1987a). Risk of therapy related leukemia and preleukemia after Hodgkin's Disease: Relation to Age, Cumulative dose of Alkylating agents and Time from Chemotherapy. Lancet July 11, 83-89. Pedersen-Bjergaard J, Philip P (1987b) Chromosome characteristics of therapy-related acute non-lymphocytic leukemia and preleukemia: Possible implications <strong>for</strong> pathogenesis of the disease. Leuk.Res. 11:315-318. Pedersen-Bjergaard, J., Pedersen, M., Roulston, D., and Philip, P. (1995). Different genetic pathways in leukemogenesis <strong>for</strong> patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 86, 3542-3552. Pedersen-Bjergaard, J., Timshel, S., Andersen, M. K., Andersen, A. S., and Philip, P. (1998) Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases. Genes, Chromosomes & Cancer 23(4), 337-49. Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H., and Nerlov, C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. 2002. Blood. 99(6), 1909-12. Phillips, M.L., Esmen, N.A., Hall, T.A., and Lynch, R. 2004. Determinants of exposure to volatile organic compounds in four Oklahoma cities. Journal of Exposure Analysis and Environmental Epidemiology, 2004, (1-12. Benzene <strong>VCCEP</strong> <strong>Submission</strong> 223 March 2006
Picciani, D. 1979. Cytogenetic study of workers exposed to benzene. Environ Res 19: 33-38. Plappert, U., Barthel, E., Raddatz, K., et al. 1994. Early effects of benzene exposure in mice: Hematological versus genotoxic effects. Arch Toxicol 68: 284-290. Plappert U, Barthel E, Seidel HJ (1994) Reduction of benzene toxicity by toluene. Environ.Mol.Mutagen. 24:283-292 Pollini, G., and Columbi, R. (1964). Il danno cromosomico dei linfociti nel'emopatia benzenica. Med Lav 55, 653-654. Pope and Rall Eds. Case Studies in Environmental Medicine: Gasoline. Committee on Curriculum Development in Environmental Medicine, Institute of Medicine 992 pages. In: Environmental Medicine: Integrating a Missing Element into Medical Education, Washington DC: National Academy Press. Popp, W., Vahrenholz, C., Yaman, S., et al. 1992. Investigations of the frequency of DNA strand breakage and cross-linking in lymphocytes of female workers exposed to benzene and toluene. Carcinogenesis 13: 57-61. Powley MW and Carlson GP (1999). Species comparison of hepatic and pulmonary metabolism of benzene, Toxicology. 139: 207-217. Powley MW and Carlson GP (2000). Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes. J Biochem Mol Toxicol. 14: 303-309. Powley MW and Carlson GP (2001). Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice. Toxicology. 169: 187-194. Pushkina, N.N., Gofmekler, V.A., and Klevtsova. 1968. Changes in content of ascorbic acid and nucleic acids produced by benzene and <strong>for</strong>maldehyde. Bull Exp Biol Med 66: 51-532. Pyatt D, Hays S, Cushing C. (2005). Do children have increased susceptibility <strong>for</strong> developing secondary acute myelogenous leukemia? Chemico-Biological Interactions 153-154:223-229. Pyatt D, Hays S. (2006 in press). Is age an independent risk factor <strong>for</strong> chemically induced acute myelogenous leukemia? Pyatt DW, Yang Y, Stillman W, Irons RD (2000) Hydroquinone inhibits PMA-induced activation of NF-kB in primary human CD19+ B lymphocytes. Cell Biology and Toxicology 16:41-51 Qu Q, Shore R, Li G, Jin X, Chen L, Cohen B, Melikian A, Eastmond D, Rappaport S, Yin S, Li H, Waidyanatha S, Li Y, Mu R, Zhang X, Li K (2002) Hematological changes among Chinese workers with a broad range of benzene exposures. American Journal of Industrial Medicine 42:275-285 Quitt M, Cassel A, Yoffe A, Anatol A, Froom P (2004) Autonomous growth of committed hematopoietic progenitors from peripheral blood of workers exposed to low levels of benzene. JOEM 46:27-29 Benzene <strong>VCCEP</strong> <strong>Submission</strong> 224 March 2006
- Page 1 and 2:
Voluntary Children’s Chemical Eva
- Page 3 and 4:
6.1.2 Types of Adverse Health Effec
- Page 5 and 6:
Glossary of Terms μg Microgram AA
- Page 7 and 8:
STEL Short-Term Exposure Limit TEAM
- Page 9 and 10:
enzene induced pancytopenias can pr
- Page 11 and 12:
A fertility study in female rats ex
- Page 13 and 14:
estimate is very conservative both
- Page 15 and 16:
2.0 BASIS FOR INCLUSION OF BENZENE
- Page 17 and 18:
2.5 Air Monitoring Data Several of
- Page 19 and 20:
Table 3.1: Proposed Benzene AEGL Va
- Page 21 and 22:
4.0 Regulatory Overview This sectio
- Page 23 and 24:
passenger vehicles operated at cold
- Page 25 and 26:
Benzene has been designated a hazar
- Page 27 and 28:
products had ceased” [46 Fed. Reg
- Page 29 and 30:
5.0 CHEMICAL OVERVIEW This section
- Page 31 and 32:
Table 5.3: Environmental Fate and T
- Page 33 and 34:
general, the production rate is abo
- Page 35 and 36:
gasoline. Aromatic hydrocarbons, su
- Page 37 and 38:
The EPA Office of Air Quality Plann
- Page 39 and 40:
Benzene VCCEP Submission March 2006
- Page 41 and 42:
Table 5.11: Benzene Releases for Al
- Page 43 and 44:
6.1.2.2 Chronic Toxicity Toxicity a
- Page 45 and 46:
6.1.2.2e Other Hematopoietic Malign
- Page 47 and 48:
that transient, high peak exposures
- Page 49 and 50:
absorption compared to inhalation,
- Page 51 and 52:
increased risk of disease. It shoul
- Page 53 and 54:
The National Cancer Institute (NCI)
- Page 55 and 56:
exposure. This was also supported b
- Page 57 and 58:
follow-up of this same cohort, Wong
- Page 59 and 60:
development of MDS)and/or AML. It i
- Page 61 and 62:
quantification of benzene air conce
- Page 63 and 64:
4.0, 95% CI = 1.8-9.3) but not ALL
- Page 65 and 66:
6.2 Benzene Toxicology—Animal Haz
- Page 67 and 68:
eakage and loss was comparable whet
- Page 69 and 70:
Benzene VCCEP Submission March 2006
- Page 71 and 72:
Table 6.2: In Vivo Genotoxicity of
- Page 73 and 74:
Table 6.2 Continued: In Vivo Genoto
- Page 75 and 76:
6.2.2.3 Transplacental Genotoxicity
- Page 77 and 78:
induce solid tumors in animals in t
- Page 79 and 80:
mice in the 300-ppm group had bilat
- Page 81 and 82:
decreases in maternal weight gain,
- Page 83 and 84:
Benzene VCCEP Submission March 2006
- Page 85 and 86:
Benzene VCCEP Submission March 2006
- Page 87 and 88:
increased resorptions. The effects
- Page 89 and 90:
proposed that transplacental effect
- Page 91 and 92:
glycerol lysis time, and incidence
- Page 93 and 94:
6.2.5.2 Chronic Toxicity Repeat-dos
- Page 95 and 96:
LOAELs for carcinogenic effects in
- Page 97 and 98:
the measurements of doses are suspe
- Page 99 and 100:
intracellular pathogen, Listeria mo
- Page 101 and 102:
2. Evidence indicates that myelotox
- Page 103 and 104:
7.0 Exposure Assessments This secti
- Page 105 and 106:
throughout childhood, see Table 7.1
- Page 107 and 108:
7.2 Sources of Benzene Exposure Chi
- Page 109 and 110:
Table 7.3: Outdoor Ambient Air Benz
- Page 111 and 112:
Table 7.5: County-Wide 24-hour Ambi
- Page 113 and 114:
Age-specific benzene intakes are pr
- Page 115 and 116:
Table 7.9: Total ADDs for Exposure
- Page 117 and 118:
Table 7.10 (cont.) Study Location a
- Page 119 and 120:
Table 7.11: Summary of Benzene Meas
- Page 121 and 122:
factor change attributable to benze
- Page 123 and 124:
where: ADD = average daily dose (mg
- Page 125 and 126:
Table 7.16: Total ADDS from In-Home
- Page 127 and 128:
Table 7.18: Summary of Age-Specific
- Page 129 and 130:
Table 7.20: Summary Statistics for
- Page 131 and 132:
Benzene VCCEP Submission March 2006
- Page 133 and 134:
Benzene VCCEP Submission March 2006
- Page 135 and 136:
In-Vehicle Exposures In-vehicle exp
- Page 137 and 138:
Table 7.30: Average of Mean In-Vehi
- Page 139 and 140:
e similar to those in other U.S. st
- Page 141 and 142:
vehicle); the total amount of time
- Page 143 and 144:
use of small non-road engine equipm
- Page 145 and 146:
Children may be exposed to benzene
- Page 147 and 148:
Table 7.36: Typical School Year Wee
- Page 149 and 150:
An addition of less than 1 µg/m 3
- Page 151 and 152:
In the mid-1990s, the American Petr
- Page 153 and 154:
Table 7.44: Dermal Benzene Absorpti
- Page 155 and 156:
Table 7.47: Product Names and Manuf
- Page 157 and 158:
Table 7.49: Summary of Age-Specific
- Page 159 and 160:
For children and non-smoking adults
- Page 161 and 162:
Benzene Exposure (mg/kg-day) Figure
- Page 163 and 164:
ackground pathways of exposure, inc
- Page 165 and 166:
8.1.3 EPA Default Risk Assessment N
- Page 167 and 168:
8.2.1 Potential for Increased Sensi
- Page 169 and 170:
These findings illustrate examples
- Page 171 and 172:
information associated with benzene
- Page 173 and 174:
species are more sensitive than oth
- Page 175 and 176:
8.2.3.1 Point of Departure for Non-
- Page 177 and 178:
Cancer risks were calculated using
- Page 179 and 180: NONCANCER HAZARD QUOTIENT 1.00 0.09
- Page 181 and 182: Table 8.1. Derivation of noncancer
- Page 183 and 184: Table 8.3. Points of departure for
- Page 185 and 186: Table 8.4. (cont.) Noncancer Hazard
- Page 187 and 188: Table 8.5. Noncancer hazard quotien
- Page 189 and 190: Table 8.6. Cancer risk estimates as
- Page 191 and 192: Table 8.7. Indoor air comparison (i
- Page 193 and 194: Table 8.9. Noncancer margins of saf
- Page 195 and 196: Table 8.10. Noncancer margins of sa
- Page 197 and 198: Table 8.11. Indoor air comparison (
- Page 199 and 200: Table 8.13. (cont.) Notes: Cancer M
- Page 201 and 202: the continental U.S. for each leuke
- Page 203 and 204: in significant reductions in benzen
- Page 205 and 206: Aksoy M (1977) Leukemia in workers
- Page 207 and 208: Austin, C.C., Wang, D., Ecobichon,
- Page 209 and 210: Buckley, J.D., Ribison, L.L., Swoti
- Page 211 and 212: CONCAWE. 1996. Scientific basis for
- Page 213 and 214: Ding, X-J, Li, Y., Ding, Y. el al.
- Page 215 and 216: Forni, A. 1994. Comparison of chrom
- Page 217 and 218: Goldwater LJ (1941) Disturbances in
- Page 219 and 220: Hsieh, G.C., Parker, R.D., and Shar
- Page 221 and 222: Jo, W.K. and Park, K.H. 1998. Expos
- Page 223 and 224: Lange, A., Smolik, R., Zatonski, W.
- Page 225 and 226: Lynge E, Andersen A, Nilsson R, Bar
- Page 227 and 228: Meadows, A., Obringer, A. M. O., Ba
- Page 229: Nedelcheva V, Gut I, Soucek P, Tich
- Page 233 and 234: Ross D, Siegel D, Gibson NW, Pachec
- Page 235 and 236: Sathiakumar, N., Delzell, E., Cole,
- Page 237 and 238: Smith, M. T., Zhang, L. P., Wang, Y
- Page 239 and 240: Thomas, K.W., Pellizzari, E.D., Cla
- Page 241 and 242: United States Environmental Protect
- Page 243 and 244: URS. 2002. Air Quality Trend in the
- Page 245 and 246: Weisel, C.P. 2002. Assessing exposu
- Page 247 and 248: Xing, S.G., Shi, X., Wu, Z.L., Chen